215 related articles for article (PubMed ID: 32311119)
1. Alternative assays to dRVVT and aPTT for lupus anticoagulant detection.
Moore GW
Am J Hematol; 2020 Aug; 95(8):992-998. PubMed ID: 32311119
[TBL] [Abstract][Full Text] [Related]
2. Paired APTTs of low and high lupus anticoagulant sensitivity permit distinction from other abnormalities and achieve good lupus anticoagulant detection rates in conjunction with dRVVT.
Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
Int J Lab Hematol; 2019 Feb; 41(1):60-68. PubMed ID: 30248243
[TBL] [Abstract][Full Text] [Related]
3. Taipan snake venom time coupled with ecarin time enhances lupus anticoagulant detection in nonanticoagulated patients.
Moore GW; Culhane AP; Maloney JC; Archer RA; Breen KA; Hunt BJ
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):477-80. PubMed ID: 26656903
[TBL] [Abstract][Full Text] [Related]
4. Triple-positive antiphospholipid syndrome does not guarantee positivity in each lupus anticoagulant assay.
Moore GW; Foxton E; Platton S; Yartey N; White D; MacDonald SG
J Thromb Haemost; 2023 Dec; 21(12):3539-3546. PubMed ID: 37597725
[TBL] [Abstract][Full Text] [Related]
5. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
6. Testing for Lupus Anticoagulants.
Moore GW
Semin Thromb Hemost; 2022 Sep; 48(6):643-660. PubMed ID: 35649428
[TBL] [Abstract][Full Text] [Related]
7. Lupus anticoagulants: pathogenesis and laboratory diagnosis.
Court EL
Br J Biomed Sci; 1997 Dec; 54(4):287-98. PubMed ID: 9624740
[TBL] [Abstract][Full Text] [Related]
8. Newly developed dilute Russell's viper venom reagents for lupus anticoagulant detection with improved specificity.
Moore GW; Peyrafitte M; Dunois C; Amiral J
Lupus; 2018 Jan; 27(1):95-104. PubMed ID: 28549386
[TBL] [Abstract][Full Text] [Related]
9. The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants.
Ząbczyk M; Kopytek M; Natorska J; Undas A
Clin Chem Lab Med; 2019 Aug; 57(9):1374-1381. PubMed ID: 30763261
[TBL] [Abstract][Full Text] [Related]
10. Lupus anticoagulant diagnosis in patients receiving direct oral FXa inhibitors at trough levels: A real-life study.
Gay J; Duchemin J; Imarazene M; Fontenay M; Jourdi G
Int J Lab Hematol; 2019 Dec; 41(6):738-744. PubMed ID: 31487115
[TBL] [Abstract][Full Text] [Related]
11. Applying index of circulating anticoagulant to mixing tests with lupus anticoagulant screen and confirm reagents can distinguish with high specificity between lupus anticoagulants and direct factor Xa inhibitors.
Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
Int J Lab Hematol; 2021 Aug; 43(4):771-778. PubMed ID: 33974363
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of sensitivity and specificity of confirmatory assays for lupus anticoagulant (LA) detection].
Imoto K; Yasumuro Y; Taki M; Suzuki Y; Akatu S; Tajima C; Ichikawa Y
Rinsho Byori; 1996 Aug; 44(8):797-801. PubMed ID: 8816068
[TBL] [Abstract][Full Text] [Related]
13. Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome.
Arachchillage DR; Mackie IJ; Efthymiou M; Isenberg DA; Machin SJ; Cohen H
J Thromb Haemost; 2015 Jul; 13(7):1264-73. PubMed ID: 25850997
[TBL] [Abstract][Full Text] [Related]
14. Mixing test specific cut-off is more sensitive at detecting lupus anticoagulants than index of circulating anticoagulant.
Moore GW; Culhane AP; Daw CR; Noronha CP; Kumano O
Thromb Res; 2016 Mar; 139():98-101. PubMed ID: 26916303
[TBL] [Abstract][Full Text] [Related]
15. Use of a simplified dilute Russell's viper venom time (DRVVT) confirms heterogeneity among 'lupus anticoagulants'.
Exner T; Papadopoulos G; Koutts J
Blood Coagul Fibrinolysis; 1990 Aug; 1(3):259-66. PubMed ID: 2129412
[TBL] [Abstract][Full Text] [Related]
16. Taipan snake venom time has high sensitivity for lupus anticoagulants in non-anticoagulated, triple positive antiphospholipid syndrome patients.
Moore GW; Platton S; Yartey N; Foxton E; White D; MacDonald SG
Int J Lab Hematol; 2024 Jun; 46(3):538-545. PubMed ID: 38303489
[TBL] [Abstract][Full Text] [Related]
17. Real-world evidence of lupus anticoagulant testing: simultaneous positivity of diluted Russell's viper venom time and silica clotting time increases thrombotic risk prediction.
Lee Y; Gu JY; Kim HK
J Thromb Thrombolysis; 2022 Aug; 54(2):318-322. PubMed ID: 35841477
[TBL] [Abstract][Full Text] [Related]
18. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
[TBL] [Abstract][Full Text] [Related]
19. Use of a new silica clotting time for diagnosing lupus anticoagulant in patients who meet the clinical criteria for antiphospholipid syndrome.
Grypiotis P; Ruffatti A; Pengo V; Tonello M; Biasiolo A; Zamboni D; Cavazzana A; Todesco S
J Clin Lab Anal; 2006; 20(1):15-8. PubMed ID: 16470527
[TBL] [Abstract][Full Text] [Related]
20. Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting.
Antovic A; Norberg EM; Berndtsson M; Rasmuson A; Malmström RE; Skeppholm M; Antovic J
Thromb Haemost; 2017 Aug; 117(9):1700-1704. PubMed ID: 28640321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]